The Cardiolipin Antibody (ACL) - IgG Test is a crucial diagnostic blood test used to detect and quantify IgG class antibodies directed against cardiolipin, a key phospholipid found in cell membranes. This test is a primary tool in the diagnosis of Antiphospholipid Syndrome (APS), an autoimmune disorder characterized by unexplained blood clotting (thrombosis) and pregnancy-related complications, such as recurrent miscarriages. Elevated levels of IgG-type ACL antibodies are strongly associated with the risk of these thrombotic events. The test is often ordered alongside IgM and IgA isotypes to provide a comprehensive profile for APS assessment and management.

The Cardiac Risk Marker Test is an advanced diagnostic panel designed to evaluate an individual's long-term likelihood of developing cardiovascular disease or experiencing a heart attack.
Unlike standard lipid profiles, this specialized test measures specific blood biomarkers—such as High-Sensitivity C-Reactive Protein (hs-CRP), Lipoprotein(a), Homocysteine, and Apolipoproteins—which detect hidden inflammation, plaque instability, and genetic predispositions to arterial blockage.
It is especially valuable for individuals with a family history of heart disease, normal cholesterol levels but unexplained cardiac events, or chronic conditions like diabetes. This crucial test enables early, targeted preventive interventions.

The Cardiac Profile - OPD Package is a comprehensive outpatient health check designed for the early detection, evaluation, and prevention of cardiovascular diseases.
Tailored for individuals with risk factors such as high blood pressure, diabetes, stress, or a family history of heart conditions, this screening bundle typically includes vital diagnostic evaluations like an Electrocardiogram (ECG), Lipid Profile, Fasting Blood Sugar, and a cardiologist consultation.
By assessing key markers of heart health efficiently in a single visit, this package empowers patients to proactively manage their wellness, prevent critical cardiac events, and ensure long-term vitality.

The Beta-2 Glycoprotein 1 IgG test is an automated immunoassay used to detect IgG-class autoantibodies directed against beta-2 glycoprotein 1, a key plasma protein. Elevated levels of these autoantibodies are strongly associated with antiphospholipid syndrome (APS), a systemic autoimmune condition characterized by recurrent arterial or venous thrombosis and adverse pregnancy outcomes. Along with lupus anticoagulant and anticardiolipin antibodies, this test serves as a major diagnostic criterion for APS. Identifying these antibodies helps clinicians stratify thrombotic risk, evaluate unexplained blood clotting events, and guide long-term management and therapeutic anticoagulation strategies for affected patients.

An **Aspartate Aminotransferase (SGOT/AST) Test** is a crucial diagnostic blood assay used to measure levels of the AST enzyme in the bloodstream. While primarily found in the liver, AST is also present in heart tissue, skeletal muscles, kidneys, and the brain.
Elevated SGOT levels typically indicate cellular injury or tissue damage, commonly resulting from liver conditions like hepatitis, cirrhosis, or fatty liver disease, as well as muscle trauma or cardiac events. Often evaluated alongside Alanine Aminotransferase (ALT), this test helps healthcare providers assess liver functionality, monitor disease progression, and determine the underlying cause of organ injury.

An **Antiphospholipid Antibody (APLA) Profile Test** is a specialized group of blood tests used to diagnose Antiphospholipid Syndrome (APS), an autoimmune condition. In APS, the body mistakenly produces autoantibodies against its own proteins bound to phospholipids. This reaction significantly increases the risk of abnormal blood clotting in veins or arteries, as well as pregnancy complications like recurrent miscarriages.
The APLA panel typically measures three primary markers: lupus anticoagulant, anticardiolipin antibodies, and anti-beta-2 glycoprotein I antibodies. Identifying these autoantibodies helps clinicians evaluate a patient's risk of thrombotic events, guiding appropriate preventive care and targeted anticoagulant treatments.

### **Anti-Sperm Antibody (ASAB)**
**Anti-Sperm Antibodies (ASAB)** are immunoglobulins that mistakenly target sperm as foreign invaders. They can be present in both male and female reproductive tracts.
* **Impact on Fertility:** ASABs bind to sperm, causing them to clump together (agglutination), which severely hinders their motility and prevents them from swimming through the female cervical mucus.
* **Fertilization Barrier:** By coating the sperm head, these antibodies can block the crucial sperm-egg interaction, preventing successful fertilization.
* **Clinical Detection:** Commonly diagnosed using Semen Analysis (Mixed Antiglobulin Reaction / Immunobead tests) or blood ELISA assays, guiding decisions for assisted reproductive treatments like IVF or ICSI.

**Anti-cardiolipin (aCL) IgG and IgM antibodies** are autoantibodies—immune proteins that mistakenly target the body's own cell membranes, specifically phospholipids.
Testing for both types is essential when evaluating unexplained blood clots, recurrent miscarriages, or autoimmune diseases like systemic lupus erythematosus (SLE). **IgM** antibodies usually appear first during an initial immune response, while **IgG** antibodies develop later and typically persist longer, often carrying a stronger clinical association with clotting risks.
Elevated levels of either antibody serve as primary diagnostic markers for **Antiphospholipid Syndrome (APS)**, a condition requiring careful medical management to prevent future thrombotic events.

Albumin is the most abundant protein found in human blood plasma, primarily produced by the liver. It acts as a vital carrier molecule, transporting essential substances like hormones, vitamins, enzymes, and medications throughout the body.

Crucially, albumin maintains oncotic pressure, a counter-pressure that prevents fluid from leaking out of blood vessels into surrounding tissues.

A simple blood test measuring albumin levels helps evaluate liver function, kidney health, and nutritional status. Low levels often signal underlying issues, such as liver disease, kidney malfunction, or severe malnutrition, causing fluid buildup and swelling (edema) in the body.

This rapid, automated DNA test detects active Tuberculosis (M.Tb) and checks for resistance to the two most critical first-line TB medications: Rifampicin and Isoniazid.

Using advanced CBNAAT (GeneXpert) technology, the test analyzes samples (like sputum, fluid, or tissue) to identify bacterial DNA within hours. Simultaneously, it maps genetic mutations responsible for drug resistance.

By confirming whether the infection is standard TB or drug-resistant TB (such as MDR-TB), this test prevents critical treatment delays. It allows doctors to bypass weeks of traditional lab cultures and immediately prescribe the most effective, lifesaving antibiotic regimen.